Arrayit Corporation (ARYC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2014 | 1.05 Million USD | 121.14% |
| 2013 | 477.34 Thousand USD | -54.89% |
| 2012 | 1.05 Million USD | -19.69% |
| 2011 | 1.31 Million USD | 8.42% |
| 2010 | 1.21 Million USD | 14.14% |
| 2009 | 1.06 Million USD | -71.34% |
| 2008 | 3.71 Million USD | 72.55% |
| 2007 | 2.15 Million USD | -25.92% |
| 2006 | 2.9 Million USD | 181.04% |
| 2005 | 1.03 Million USD | -3.99% |
| 2004 | 1.07 Million USD | 39.99% |
| 2003 | 769.33 Thousand USD | 3116.75% |
| 2002 | -25.5 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2015 Q1 | 1.17 Million USD | 11.47% |
| 2015 Q3 | 924.49 Thousand USD | -9.75% |
| 2015 Q2 | 1.02 Million USD | -12.95% |
| 2014 Q3 | 835.98 Thousand USD | 14.61% |
| 2014 Q4 | 1.05 Million USD | 26.27% |
| 2014 FY | 1.05 Million USD | 121.14% |
| 2014 Q1 | 551.3 Thousand USD | 15.5% |
| 2014 Q2 | 729.39 Thousand USD | 32.3% |
| 2013 Q4 | 477.34 Thousand USD | -46.91% |
| 2013 Q3 | 899.03 Thousand USD | 1.32% |
| 2013 Q2 | 887.3 Thousand USD | -6.03% |
| 2013 Q1 | 944.2 Thousand USD | -10.78% |
| 2013 FY | 477.34 Thousand USD | -54.89% |
| 2012 FY | 1.05 Million USD | -19.69% |
| 2012 Q1 | 1.32 Million USD | 0.86% |
| 2012 Q3 | 1.32 Million USD | 0.0% |
| 2012 Q4 | 1.05 Million USD | -20.17% |
| 2011 Q2 | 1.19 Million USD | -1.9% |
| 2011 Q4 | 1.31 Million USD | 7.75% |
| 2011 Q3 | 1.22 Million USD | 2.67% |
| 2011 Q1 | 1.21 Million USD | -0.1% |
| 2011 FY | 1.31 Million USD | 8.42% |
| 2010 Q1 | 1.01 Million USD | -4.28% |
| 2010 FY | 1.21 Million USD | 14.14% |
| 2010 Q4 | 1.21 Million USD | 1.32% |
| 2010 Q3 | 1.19 Million USD | 6.65% |
| 2010 Q2 | 1.12 Million USD | 10.35% |
| 2009 Q1 | 1.75 Million USD | -52.65% |
| 2009 FY | 1.06 Million USD | -71.34% |
| 2009 Q2 | 1.74 Million USD | -0.93% |
| 2009 Q4 | 1.06 Million USD | 0.0% |
| 2008 Q2 | 3.45 Million USD | -3.78% |
| 2008 Q1 | 3.59 Million USD | 66.85% |
| 2008 Q3 | 3.38 Million USD | -1.99% |
| 2008 Q4 | 3.71 Million USD | 9.67% |
| 2008 FY | 3.71 Million USD | 72.55% |
| 2007 Q4 | 2.15 Million USD | 145.43% |
| 2007 FY | 2.15 Million USD | -25.92% |
| 2007 Q1 | 2.96 Million USD | 2.05% |
| 2007 Q2 | 754.08 Thousand USD | -74.57% |
| 2007 Q3 | 877.1 Thousand USD | 16.31% |
| 2006 Q3 | 2.44 Million USD | 182.58% |
| 2006 FY | 2.9 Million USD | 181.04% |
| 2006 Q1 | 929.54 Thousand USD | -10.1% |
| 2006 Q4 | 2.9 Million USD | 18.92% |
| 2006 Q2 | 864.74 Thousand USD | -6.97% |
| 2005 Q1 | 256.15 Thousand USD | -76.22% |
| 2005 FY | 1.03 Million USD | -3.99% |
| 2005 Q3 | 1.52 Million USD | 12.89% |
| 2005 Q4 | 1.03 Million USD | -32.25% |
| 2005 Q2 | 1.35 Million USD | 427.74% |
| 2004 Q3 | 1.67 Million USD | -21.26% |
| 2004 FY | 1.07 Million USD | 39.99% |
| 2004 Q2 | 2.13 Million USD | 42.0% |
| 2004 Q1 | 1.5 Million USD | 94.98% |
| 2004 Q4 | 1.07 Million USD | -35.78% |
| 2003 Q2 | 103 Thousand USD | 30573.37% |
| 2003 Q4 | 769.33 Thousand USD | -2.68% |
| 2003 Q1 | -338.00 USD | 98.67% |
| 2003 Q3 | 790.49 Thousand USD | 667.47% |
| 2003 FY | 769.33 Thousand USD | 3116.75% |
| 2002 Q3 | 530.07 Thousand USD | 0.0% |
| 2002 FY | -25.5 Thousand USD | 0.0% |
| 2002 Q4 | -25.5 Thousand USD | -104.81% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 52.15% |
| Atlantic International Corp. | 236.49 Thousand USD | -346.342% |
| Biocept, Inc. | -788 Thousand USD | 233.957% |
| Bioqual, Inc. | -12 Million USD | 108.791% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | -4542.157% |
| DermTech, Inc. | 17.65 Million USD | 94.02% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 100.184% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 114.309% |
| iMD Companies, Inc. | 1.11 Million USD | 5.407% |
| IDenta Corp. | 524.85 Thousand USD | -101.12% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 86.28% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 4016.518% |
| InVitro International | -313.14 Thousand USD | 437.093% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 32.59% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 148147.686% |
| Medical Imaging Corp. | 3.79 Million USD | 72.155% |
| NovelStem International Corp. | 3.52 Million USD | 70.025% |
| Optigenex Inc. | 8.93 Million USD | 88.185% |
| PharmChem, Inc. | -1.49 Million USD | 170.635% |
| Proteome Sciences plc | 14.57 Million USD | 92.757% |
| Response Genetics, Inc | -13.08 Million USD | 108.066% |
| Rennova Health, Inc. | 14.82 Million USD | 92.882% |
| RushNet, Inc. | 4.8 Million USD | 78.013% |
| ScreenPro Security Inc. | 135.58 Thousand USD | -678.514% |
| Stella Diagnostics Inc. | 6.19 Million USD | 82.955% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 40.844% |
| Todos Medical Ltd. | 38.31 Million USD | 97.245% |